Corcept Therapeutics, Inc.

... ...
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. -1.89%27.0014.1%$158.87m
HZNPHorizon Therapeutics Plc -0.95%80.435.6%$158.03m
ACRSAclaris Therapeutics, Inc. -4.57%17.975.3%$136.21m
CTLTCatalent, Inc. -0.13%119.672.1%$103.91m
BHCBausch Health Cos., Inc. -1.89%27.000.0%$102.08m
JAZZJazz Pharmaceuticals Plc 0.17%167.292.4%$86.77m
ACSTAcasti Pharma, Inc. 18.64%0.760.2%$71.66m
ISRIsoRay, Inc. 2.08%2.462.5%$65.10m
UTHRUnited Therapeutics Corp. -0.26%171.1714.1%$64.58m
AMRNAmarin Corp. Plc -1.43%6.201.5%$50.03m
PRGOPerrigo Co. Plc -0.44%43.286.8%$49.66m
GWPHGW Pharmaceuticals Plc 0.02%136.936.1%$48.40m
SAGESAGE Therapeutics, Inc. 1.85%91.217.6%$46.77m
ARGXargenx SE 6.40%305.360.0%$43.44m
ICLRICON plc 2.72%220.964.2%$41.59m

Company Profile

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.